Reading the annual reports…
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
GRDN · NYSE · United States · Retail-Drug Stores And Proprietary Stores
In shortGuardian Pharmacy Services, Inc. is profitable, generates cash and holds more cash than debt, with revenue growing (+17.9% last year).
Financial health
Solid
Built from five areas over the last five annual reports. Tap an area to see the figures behind it.
| Operating marginShare of each sale left after running the business, before interest and tax. | 5.0% | 33/100 |
|---|---|---|
| Net marginShare of each sale left as profit after every cost, interest and tax. | 3.4% | 34/100 |
| Return on equityProfit earned on the money shareholders put in. Above 15% is strong. | 26.8% | 100/100 |
| Return on invested capitalProfit earned on all the capital used (equity and debt). Above 10% usually means a real competitive edge. | 22.2% | 100/100 |
Weight in the score: 25%
| Current ratioShort-term assets divided by short-term debts. Below 1 can mean tight cash. | 1.38× | 48/100 |
|---|---|---|
| Debt / equityDebt compared with the shareholders' stake. Above 2 is heavily indebted. | 0.00× | 100/100 |
| Net debt / EBITDAYears of operating profit needed to repay net debt. Below 2 is comfortable. | Net cash | 100/100 |
| Interest coverageHow many times operating profit covers interest. Below 2 is risky. | 109.32× | 100/100 |
| Altman Z''Bankruptcy-risk model. Above 2.6 safe, below 1.1 distress. | 3.85 | 71/100 |
Weight in the score: 25%
| Free cash flow marginCash left from each sale after investments. The money that can pay dividends or reduce debt. | 6.0% | 44/100 |
|---|---|---|
| Free cash flow / net incomeHow much accounting profit turns into real cash. Near 1 or above is healthy. | 1.76× | 100/100 |
| Years with positive free cash flow (last 5) | 2 of 2 | 100/100 |
Weight in the score: 20%
| Profitable years (last 5) | 1 of 2 | 50/100 |
|---|---|---|
| Years of revenue decline (last 5) | 0 of 1 | 100/100 |
| Revenue growth volatility | – | n/a |
| Operating margin volatility | 7.2% | 44/100 |
Weight in the score: 20%
Fiscal year 2025 · change vs prior year
Annual figures as reported. Hover a bar or point for the exact value.
The last 2 fiscal years from the company's annual reports.
USD millions; negative values in parentheses.
| Fiscal year | FY24 | FY25 |
|---|---|---|
| Revenue | 1,228 | 1,449 |
| Cost of revenue | 984 | 1,156 |
| Gross profit | 244 | 293 |
| Selling, general & admin | 307 | 220 |
| Operating income | (63) | 73 |
| Interest expense | 3.3 | 0.7 |
| Pre-tax income | (66) | 73 |
| Income tax | 4.6 | 24 |
| Net income | (110) | 49 |
3.85 Safe zone
Estimates bankruptcy risk from working capital, retained earnings, operating profit and equity. Above 2.6 is considered safe, below 1.1 signals distress.
7/9
Nine yes-or-no tests on profitability, debt, liquidity and efficiency versus the prior year. 7 to 9 is strong, 0 to 3 is weak.
All figures: SEC EDGAR. Ratios and scores are computed by Scorvest (see how it works). Information only, not investment advice. How it works
Latest annual report: Jun 30, 2026 · Data updated Aug 6, 2026